Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis [Phase 3]
A Phase 3 trial evaluating ASP1585 in chronic kidney disease patients with hyperphosphatemia not on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Bioequivalence Study of BAY77-1931 Granule [Phase 1]
This document reports the completion of a Phase 1 bioequivalence study of BAY77-1931 Granule for hyperphosphatemia.
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone [Phase 2]
Phase 2 study evaluating long-term lanthanum carbonate treatment in hyperphosphatemia patients on dialysis to measure lanthanum concentratio…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia [Phase 3]
Phase 3 study of MCI-196 in patients with chronic kidney disease on dialysis and hyperphosphatemia has completed; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients
A completed clinical trial evaluated the effect of magnesium oxide on plasma phosphate levels in hemodialysis patients with hyperphosphatemi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: BAY 77-1931 Long-term Extension From Phase II Study [Phase 2]
Update on the long-term extension of BAY 77-1931 from a Phase II trial in hyperphosphatemia, including interim safety/tolerability observati…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate [Phase 3]
A Phase 3 double-blind trial comparing lanthanum carbonate (BAY77-1931) with calcium carbonate for hyperphosphatemia has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia [Phase 2]
Phase 2 study evaluating HS219 in chronic kidney disease patients on hemodialysis with hyperphosphatemia; the trial completed and results we…
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Nicotinamide in Hemodialysis Patients With Hyperphosphatemia [Phase 2]
A Phase 2 clinical trial evaluating nicotinamide for hyperphosphatemia in patients on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-15Clinical Trial Update: PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum [NA]
A completed clinical trial evaluating the pharmacodynamic phosphate-binding properties of K2CG Chewing Gum for hyperphosphatemia in chronic …
-
CLINICAL_TRIALS trial_result · 2011-11-15Clinical Trial Update: A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia [Phase 3]
A Phase III, randomized trial evaluating combination therapy with calcium-based phosphate binders for hyperphosphatemia in chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Long-term Effect of Lanthanum Carbonate on Bone
A completed clinical trial assessing the long-term effects of lanthanum carbonate on bone health in patients with hyperphosphatemia; results…
-
CLINICAL_TRIALS trial_result · 2011-03-22Clinical Trial Update: A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis [Phase 2]
Phase 2 study of ASP1585 in chronic kidney disease patients with hyperphosphatemia on hemodialysis completed.
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia [Phase 1]
A Phase 1 double-blind, randomized, placebo-controlled trial evaluating FOSTRAP chewing gum in patients with chronic kidney disease and hype…
-
CLINICAL_TRIALS trial_result · 2009-04-01Clinical Trial Update: Phosphorus Improvement Pilot Study [NA]
A clinical trial update indicates the Phosphorus Improvement Pilot Study for hyperphosphatemia has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers [Phase 1]
Phase 1 bioequivalence study comparing calcium acetate oral solution to calcium acetate gelcaps in healthy volunteers. The trial aims to est…
-
CLINICAL_TRIALS trial_result · 2009-01-16Clinical Trial Update: The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients [Phase 1]
Phase 1 trial evaluating whether oral niacinamide lowers serum phosphorus in hemodialysis patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-08Clinical Trial Update: EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) [Phase 3]
Phase 3 trial update evaluating PhosLo for controlling phosphorus levels in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
A clinical trial evaluating klotho gene polymorphism in dialysis patients with hyperphosphatemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the effect of oral nicotinamide on plasma phosphorus levels in peritoneal dialysis patients …